Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention (STATUS PCI)

This study has been terminated.
(DSMB halted the study early due to futility. There were no safety concerns.)
Sponsor:
Information provided by (Responsible Party):
Allen Jeremias, Stony Brook University
ClinicalTrials.gov Identifier:
NCT01464671
First received: October 31, 2011
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)